Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Humana Inc. Stock

Price
Target price
€284.00

€284.00

0.320%
0.9
0.320%
€378.23
 
18.09.24 / Tradegate WKN: 856584 / Symbol: HUM / Name: Humana / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Humana Inc. in the next few years
Wizard

Humana Inc. Stock

The Humana Inc. stock is trending slightly upwards today, with an increase of €0.90 (0.320%) compared to yesterday's price.
With 23 Buy predictions and not a single Sell prediction Humana Inc. is an absolute favorite of our community.
With a target price of 378 € there is a positive potential of 33.1% for Humana Inc. compared to the current price of 284.0 €.
Our community identified positive and negative aspects for Humana Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Humana Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.

Humana Inc. (Symbol: HUM) is a leading healthcare and wellness company headquartered in Louisville, Kentucky, specializing in offering a diversified range of health insurance, wellness programs, and managed care plans to individual, group, government, and military customers. With a strong commitment to providing personalized, affordable, and high-quality healthcare solutions, Humana emphasizes on simplifying access and meeting the evolving needs of its vast clientele through leveraging data analytics, technology, and innovation. As a publicly traded entity, Humana’s stock is listed on the New York Stock Exchange, and it forms part of the esteemed S&P 500 index, reflecting its significant impact and presence within the highly competitive healthcare sector.

Pros and Cons of Humana Inc. in the next few years

Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Humana Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Humana Inc. 0.320% -4.634% -10.664% -35.978% -31.318% -18.297% 12.855%
UnitedHealth Group Inc. 0.020% -2.244% -0.267% 14.879% 9.696% 46.026% 150.036%
Centene Corp. -0.070% 3.136% -2.992% 8.151% 2.889% 23.838% 64.899%
Cigna Corp. -0.200% -1.248% 3.187% 20.037% 18.353% 82.777% 119.792%

Comments

Prediction Buy
Perf. (%) -13.60%
Target price 360.360
Change
Ends at 05.09.25

Humana Inc. (NYSE: HUM) had its price target raised by analysts at Royal Bank of Canada from $385.00 to $400.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Show more

Royal Bank of Canada 
0
Report Share
05.09.24
Prediction Buy
Perf. (%) -13.86%
Target price 370.240
Change
Ends at 01.08.25

Humana Inc. (NYSE: HUM) had its price target raised by analysts at Oppenheimer Holdings Inc. from $370.00 to $400.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Show more

Oppenheimer Holdings Inc. 
0
Report Share
01.08.24
Prediction Buy
Perf. (%) -20.31%
Target price 375.376
Change
Ends at 24.07.25

Humana Inc. (NYSE: HUM) had its price target raised by analysts at TD Cowen from $396.00 to $407.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat
Show more

TD Cowen 
0
Report Share
24.07.24
Show more
Not a member yet? Sign up for free!

News

New Study from Humana Healthcare Research and Harvard University Reveals Better Access to Primary Care for Seniors Receiving Care from Senior-Focused Primary Care Organizations: https://mms.businesswire.com/media/20240904301644/en/2231842/5/SFPC_Study_News_Release_Image_All_photos_courtesy_of_CenterWell_Senior_Primary_Care.jpg
New Study from Humana Healthcare Research and Harvard University Reveals Better Access to Primary Care for Seniors Receiving Care from Senior-Focused Primary Care Organizations


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, recently published a study on senior-focused primary care — a value-based care model that tailors the

BusinessWire_EN 
0 04.09.24
Humana and Evergreen Nephrology Introduce New Specialized Care Program for Patients Living with Kidney Disease: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana and Evergreen Nephrology Introduce New Specialized Care Program for Patients Living with Kidney Disease


Humana Inc. (NYSE: HUM), a leading health and well-being company, announced a new value-based kidney care program with Evergreen Nephrology designed to advance quality of care and help optimize

BusinessWire_EN 
0 29.08.24
CenterWell Home Health Launches 20th Food Fundraising Drive: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
CenterWell Home Health Launches 20th Food Fundraising Drive


CenterWell Home Health, one of America’s largest home health providers, has launched its 20th annual Food Fundraising Drive, an effort to fight food insecurity in the communities it serves.

BusinessWire_EN 
0 28.08.24